acute respiratory failure
Jump to navigation
Jump to search
Introduction
Rapid onset of life-threatening disorder in alveolar ventilation, arterial oxygenation &/or tissue oxygenation.
Etiology
- patients with chronic obstructive pulmonary disease
- increases in volume, viscosity or purulence of secretions
- increasing airway obstruction with inflammation
- blunted respiratory drive
- pharmaceutical agents
- air pollution
- pneumonia
- pulmonary embolism
- left ventricular failure (congestive heart failure)
- pneumothorax
- aspiration or drowning
- drug overdose
- status asthmaticus
- acute neuromuscular disorders
- myasthenia gravis*
- Guillain-Barre syndrome*
- hypophosphatemia (diaphragm dysfunction)
- carbon monoxide poisoning
- severe anemia
- cardiac tamponade
* most common causes of acute neurologic respiratory failure in ICU[2]
Pathology
- ventilation-perfusion (VQ) mismatch[2]
- most common cause of hypoxemic respiratory failure[2]
- alveolar collapse (atelectasis)
- alveolar filling with fluid[2]
- inadequate alveolar ventilation resulting carbon dioxide retention
- increased carbon dioxide production
- decreased respiratory drive
- excessive work of breathing
- auto-PEEP contributes to increased work of breathing during exacerbations of obstructive lung disease
- increased dead ventilation space
- neuromuscular weakness
Laboratory
- arterial blood gas
- an acute drop in paO2 of 15 mm of Hg indicates acute respiratory failure
- paO2 < 60 mm Hg or SaO2 of < 89% breathing ambient air[2]
- paO2/FiO2 < 200 mm Hg[2]
- any level of hypercapnia associated with a pH of < 7.30 should be considered acute respiratory failure
- indicated if hypercapnia even if SaO2 normalizes with oxygen administration[2]
- sputum for gram stain & culture
Diagnostic procedures
- electrocardiogram
- pulmonary function testing
- bedside vital capacity to assess impending respiratory failure in patients with neuromuscular disease[2][4]
- maximum inspiratory & expiratory pressures & positional change in vital capacity helpful in assessing neuromuscular weakness[2]
Radiology
Complications
- cardiac arrhythmias
- generally multifocal supraventricular tachycardia
- left ventricular failure
- pulmonary emboli
- gastrointestinal hemorrhage from stress ulceration
Differential diagnosis
- the need for large amounts of supplemental oxygen suggests diagnosis other than obstructive lung disease (COPD, asthma)
Management
- maintenance of oxygenation & ventilation
- maintain SaO2 >= 93%; target of 96% no better or worse than 93%[12]
- humidified high-flow oxygen delivered by nasal cannula
- creates positive airway pressure[2]
- lower mortality at 90 days, more ventilator-free days, & less respiratory discomfort than BiPAP[5][13]
- bilevel positive airway pressure (BiPAP)[3]
- open fluid-filled or collapsed alveoli (atectasis)[2]
- COPD exacerbations, cardiogenic pulmonary edema, neuromuscular disease, obesity hypoventilation syndrome
- endotracheal intubation & mechanical ventilation rate similar for BiPAP vs high-flow oxygen[5][13]
- noninvasive positive-pressure ventilation vs high-flow oxygen does not prevent subsequent intubation or lengthen survival in immunocompromised patients[6][13]
- noninvasive positive-pressure ventilation (NPPV) delivered via helmet
- confers lower risk for mortality & endotracheal intubation vs face mask NPPV[11]
- may be alternative to mechanical ventilation[9]
- for asthmatics with acute respiratory failure, endotracheal intubation recommended[2]
- bedside ultrasonography for acute respiratory failure in critically ill patients prior to emergent needle aspiration for decompression of pneumothorax
- reversal of precipitating cause
- treat infection
- in the absence of evidence of acute pneumonia, use of broad-spectrum antibiotics is controversial
- remove secretions
- tracheal suction
- postural drainage & percussion
- beta2-adrenergic agonists (albuterol) increase ciliary clearance of particles
- reverse airway constriction
- beta2-adrenergic agonist (albulterol) nebulizer
- anti-cholinergic (ipratropium, Atrovent) nebulizer
- theophylline
- treat infection
- prevent complications
- ranitidine or other H2 blocker for GI prophylaxis
- Ted hose & SCD or heparin 5000 U sq BID for prophylaxis against pulmonary embolism
- prevent aspiration
- decrease carbohydrate calories & increase fat calories for severe hypercapnia resistant to mechanical ventilation[2]
- daily rehabilitation does not reduce length of stay or improve functional status[8]
More general terms
More specific terms
- acute hypercapneic respiratory failure
- acute respiratory distress syndrome; acute lung injury (ARDS, ALI)
References
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1203-1205
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2022.
- ↑ 3.0 3.1 Nava S, Grassi M, Fanfulla F, et al. Non-invasive ventilation in elderly patients with acute hypercapnic respiratory failure: a randomised controlled trial. Age Ageing. 2011; 40:444-450 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21345841
- ↑ 4.0 4.1 Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care. 2006 Sep;51(9):1016-21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16934165
- ↑ 5.0 5.1 5.2 Frat J-P et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015 Jun 4; 372:2185. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25981908
Stephan F et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: A randomized clinical trial. JAMA 2015 Jun 16; 313:2331. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25980660 - ↑ 6.0 6.1 Lemiale V et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: A randomized clinical trial. JAMA 2015 Oct 7; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26444879
Patel BK, Kress JP. The changing landscape of noninvasive ventilation in the intensive care unit. JAMA 2015 Oct 7 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26444567 - ↑ Needham DM, Korupolu R, Zanni JM et al Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil. 2010 Apr;91(4):536-42. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20382284
- ↑ 8.0 8.1 Morris PE et al. Standardized rehabilitation and hospital length of stay among patients with acute respiratory failure: A randomized clinical trial. JAMA 2016 Jun 28; 315:2694. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27367766
Goddard SL and Adhikari NK. The challenging task of improving the recovery of ICU survivors. JAMA 2016 Jun 28; 315:2671. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27367765 - ↑ 9.0 9.1 Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: A randomized clinical trial. JAMA 2016 May 15; PMID: https://www.ncbi.nlm.nih.gov/pubmed/2717984
Beitler JR, Owens RL, Malhotra A. Unmasking a role for noninvasive ventilation in early acute respiratory distress syndrome. JAMA 2016 May 15; PMID: https://www.ncbi.nlm.nih.gov/pubmed/27179463 - ↑ Wilson JG, Matthay MA. Mechanical ventilation in acute hypoxemic respiratory failure: a review of new strategies for the practicing hospitalist. J Hosp Med. 2014 Jul;9(7):469-75. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24733692 Free PMC Article
- ↑ 11.0 11.1 Ferreyro BL, Angriman F, Munshi L et al Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure. A Systematic Review and Meta-analysis. JAMA. Published online June 4, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32336293 Free PMC article. https://jamanetwork.com/journals/jama/fullarticle/2767025
- ↑ 12.0 12.1 Schjorring OL, Klitgaard TL, Perner A et al. Lower or higher oxygenation targets for acute hypoxemic respiratory failure. N Engl J Med 2021 Jan 20; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/33471452 https://www.nejm.org/doi/10.1056/NEJMoa2032510
- ↑ 13.0 13.1 13.2 13.3 Qaseem A et al. Appropriate use of high-flow nasal oxygen in hospitalized patients for initial or postextubation management of acute respiratory failure: A clinical guideline from the American College of Physicians. Ann Intern Med 2021 Apr 27; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33900796 https://www.acpjournals.org/doi/10.7326/M20-7533
Baldomero AK et al. Effectiveness and harms of high-flow nasal oxygen for acute respiratory failure: An evidence report for a clinical guideline by the American College of Physicians. Ann Intern Med 2021 Apr 27; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33900793 https://www.acpjournals.org/doi/10.7326/M20-4675
Baldomero AK, et al Effectiveness and harms of high-flow nasal oxygen (HFNO) for acute respiratory failure: a systematic review protocol. BMJ Open. 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32051320 Free PMC article. - ↑ Munshi L Mancebo J, Brochard LJ. Noninvasive Respiratory Support for Adults with Acute Respiratory Failure. N Engl J Med 2022; 387:1688-1698 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36322846 https://www.nejm.org/doi/full/10.1056/NEJMra2204556